Keywords
Last Name
Institution

Gabrielle Goldberg

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentGeriatrics and Palliative Medicine
Address
    Other Positions
    TitleASSISTANT PROFESSOR
    InstitutionMount Sinai
    DepartmentHematology and Medical Oncology


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Harris M, Wang XG, Jiang Z, Phaeton R, Koba W, Goldberg GL, Casadevall A, Dadachova E. Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. Br J Cancer. 2013 Mar 5; 108(4):859-65.
      View in: PubMed
    2. Murphy J, Goldberg GL. Flow cytometric analysis of STAT phosphorylation. Methods Mol Biol. 2013; 967:161-5.
      View in: PubMed
    3. Epstein AS, Goldberg GR, Meier DE. Palliative care and hematologic oncology: the promise of collaboration. Blood Rev. 2012 Nov; 26(6):233-9.
      View in: PubMed
    4. Jenq RR, Curran MA, Goldberg GL, Liu C, Allison JP, van den Brink MR. Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer. PLoS One. 2012; 7(4):e35222.
      View in: PubMed
    5. Kelley AS, Back AL, Arnold RM, Goldberg GR, Lim BB, Litrivis E, Smith CB, O'Neill LB. Geritalk: communication skills training for geriatric and palliative medicine fellows. J Am Geriatr Soc. 2012 Feb; 60(2):332-7.
      View in: PubMed
    6. Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, van den Brink MR. Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood. 2011 Jul 14; 118(2):446-55.
      View in: PubMed
    7. Goldberg GR, Meier DE. A swinging pendulum: comment on "on patient autonomy and physician responsibility in end-of-life care". Arch Intern Med. 2011 May 9; 171(9):854.
      View in: PubMed
    8. Goldberg GR, Gliatto P, Karani R. Effect of a 1-week clinical rotation in palliative medicine on medical school graduates' knowledge of and preparedness in caring for seriously ill patients. J Am Geriatr Soc. 2011 Sep; 59(9):1724-9.
      View in: PubMed
    9. Goldberg GL, Dudakov JA, Reiseger JJ, Seach N, Ueno T, Vlahos K, Hammett MV, Young LF, Heng TS, Boyd RL, Chidgey AP. Sex steroid ablation enhances immune reconstitution following cytotoxic antineoplastic therapy in young mice. J Immunol. 2010 Jun 1; 184(11):6014-24.
      View in: PubMed
    10. Chuang E, Wiener N, Christos P, Kessler R, Cobham M, Donovan D, Goldberg GL, Caputo T, Doyle A, Vahdat L, Sparano JA. Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary. Ann Oncol. 2010 Oct; 21(10):2075-80.
      View in: PubMed
    11. Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U, Smith OM, King CG, Suh D, Hirschhorn-Cymerman D, Palomba L, Penack O, Holland AM, Jenq RR, Ghosh A, Tran H, Merghoub T, Liu C, Sempowski GD, Ventevogel M, Beauchemin N, van den Brink MR. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. J Clin Invest. 2010 Jan; 120(1):343-56.
      View in: PubMed
    12. Dudakov JA, Goldberg GL, Reiseger JJ, Vlahos K, Chidgey AP, Boyd RL. Sex steroid ablation enhances hematopoietic recovery following cytotoxic antineoplastic therapy in aged mice. J Immunol. 2009 Dec 1; 183(11):7084-94.
      View in: PubMed
    13. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol. 2009 Jul; 30(7):366-73.
      View in: PubMed
    14. Dudakov JA, Goldberg GL, Reiseger JJ, Chidgey AP, Boyd RL. Withdrawal of sex steroids reverses age- and chemotherapy-related defects in bone marrow lymphopoiesis. J Immunol. 2009 May 15; 182(10):6247-60.
      View in: PubMed
    15. Goldberg GL, King CG, Nejat RA, Suh DY, Smith OM, Bretz JC, Samstein RM, Dudakov JA, Chidgey AP, Chen-Kiang S, Boyd RL, van den Brink MR. Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J Immunol. 2009 May 1; 182(9):5846-54.
      View in: PubMed
    16. Holland AM, Zakrzewski JL, Goldberg GL, Ghosh A, van den Brink MR. Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation in mouse and man. Semin Immunopathol. 2008 Dec; 30(4):479-87.
      View in: PubMed
    17. Jenq RR, King CG, Volk C, Suh D, Smith OM, Rao UK, Yim NL, Holland AM, Lu SX, Zakrzewski JL, Goldberg GL, Diab A, Alpdogan O, Penack O, Na IK, Kappel LW, Wolchok JD, Houghton AN, Perales MA, van den Brink MR. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood. 2009 Feb 12; 113(7):1574-80.
      View in: PubMed
    18. Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood. 2009 Jan 22; 113(4):945-52.
      View in: PubMed
    19. Alpdogan SO, Lu SX, Patel N, McGoldrick S, Suh D, Budak-Alpdogan T, Smith OM, Grubin J, King C, Goldberg GL, Hubbard VM, Kochman AA, van den Brink MR. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation. Blood. 2008 Dec 1; 112(12):4755-64.
      View in: PubMed
    20. Goel S, Goldberg GL, Kuo DY, Muggia F, Arezzo J, Mani S. Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone. Ann Oncol. 2008 Dec; 19(12):2048-52.
      View in: PubMed
    21. Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Brentjens RJ, Lu SX, Rizzuto G, Sant'Angelo DB, Riviere I, Sadelain M, Heller G, Zúñiga-Pflücker JC, Lu C, van den Brink MR. Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol. 2008 Apr; 26(4):453-61.
      View in: PubMed
    22. Goldberg GL, Zakrzewski JL, Perales MA, van den Brink MR. Clinical strategies to enhance T cell reconstitution. Semin Immunol. 2007 Oct; 19(5):289-96.
      View in: PubMed
    23. Zakrzewski JL, Goldberg GL, Smith OM, van den Brink MR. Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends. Blood Cells Mol Dis. 2008 Jan-Feb; 40(1):44-7.
      View in: PubMed
    24. Goldberg GL, Alpdogan O, Muriglan SJ, Hammett MV, Milton MK, Eng JM, Hubbard VM, Kochman A, Willis LM, Greenberg AS, Tjoe KH, Sutherland JS, Chidgey A, van den Brink MR, Boyd RL. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol. 2007 Jun 1; 178(11):7473-84.
      View in: PubMed
    25. Goldberg GR, Morrison RS. Pain management in hospitalized cancer patients: a systematic review. J Clin Oncol. 2007 May 1; 25(13):1792-801.
      View in: PubMed
    26. Goldberg GL, Sutherland JS, Hammet MV, Milton MK, Heng TS, Chidgey AP, Boyd RL. Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation. 2005 Dec 15; 80(11):1604-13.
      View in: PubMed
    27. Alpdogan O, Hubbard VM, Smith OM, Patel N, Lu S, Goldberg GL, Gray DH, Feinman J, Kochman AA, Eng JM, Suh D, Muriglan SJ, Boyd RL, van den Brink MR. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood. 2006 Mar 15; 107(6):2453-60.
      View in: PubMed
    28. Heng TS, Goldberg GL, Gray DH, Sutherland JS, Chidgey AP, Boyd RL. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol. 2005 Sep 1; 175(5):2982-93.
      View in: PubMed
    29. Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, Heng TS, Blazar BR, Millar JL, Malin MA, Chidgey AP, Boyd RL. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol. 2005 Aug 15; 175(4):2741-53.
      View in: PubMed
    30. Gray DH, Ueno T, Chidgey AP, Malin M, Goldberg GL, Takahama Y, Boyd RL. Controlling the thymic microenvironment. Curr Opin Immunol. 2005 Apr; 17(2):137-43.
      View in: PubMed
    31. Sood BM, Timmins PF, Gorla GR, Garg M, Anderson PS, Vikram B, Goldberg GL. Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer. Int J Gynecol Cancer. 2002 Sep-Oct; 12(5):459-64.
      View in: PubMed
    32. Timmins PF, Kuo DY, Anderson PS, Fields AL, Whitney KD, Goldberg GL. Ovarian carcinoid: management of primary and recurrent tumors. Gynecol Oncol. 2000 Jan; 76(1):112-4.
      View in: PubMed
    33. Badve S, Fehmian C, Cass I, Goldberg GL, Jones JG. Malignant Brenner tumor mimicking a primary squamous cell carcinoma of the cervix. Gynecol Oncol. 1999 Sep; 74(3):487-90.
      View in: PubMed
    34. Anderson PS, Smith HO, Goldberg GL, Fields AL, Runowicz CD, Pollard JW. Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas. Gynecol Oncol. 1999 Aug; 74(2):202-7.
      View in: PubMed
    35. Beitler JJ, Anderson PS, Wadler S, Runowicz CD, Hayes MK, Fields AL, Sood B, Goldberg GL. Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival? Int J Radiat Oncol Biol Phys. 1997 Apr 1; 38(1):143-8.
      View in: PubMed
    36. Comerci JT, Fields AL, Runowicz CD, Goldberg GL. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer. Gynecol Oncol. 1997 Mar; 64(3):425-30.
      View in: PubMed
    37. Comerci JT, Runowicz CD, Fields AL, Romney SL, Palan PR, Kadish AS, Goldberg GL. Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene. Clin Cancer Res. 1997 Feb; 3(2):157-60.
      View in: PubMed
    38. Kuo DY, Mallick S, Shen HJ, DeVictoria C, Jones J, Fields AL, Goldberg GL, Runowicz CD, Horwitz SB. Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry. Clin Cancer Res. 1996 Dec; 2(12):1981-92.
      View in: PubMed
    39. Comerci JT, Runowicz CD, Flanders KC, De Victoria C, Fields AL, Kadish AS, Goldberg GL. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer. 1996 Mar 15; 77(6):1107-14.
      View in: PubMed
    40. Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res. 1996 Jan; 2(1):181-5.
      View in: PubMed
    41. Comerci JT, Jones JG, Fields AL, Runowicz CD, Goldberg GL. Squamous cell carcinoma in mature cystic teratoma in a young woman: a diagnostic and management dilemma. Eur J Gynaecol Oncol. 1996; 17(6):501-3.
      View in: PubMed
    42. Smith HO, DeVictoria CL, Garfinkel D, Anderson P, Goldberg GL, Soeiro R, Elia G, Runowicz CD. A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection. Gynecol Oncol. 1995 Jul; 58(1):92-100.
      View in: PubMed
    43. Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res. 1995 Mar; 1(3):313-25.
      View in: PubMed
    44. Goldberg GL, Gibbon DG, Smith HO, DeVictoria C, Runowicz CD, Burns ER. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer. J Clin Oncol. 1994 Nov; 12(11):2317-20.
      View in: PubMed
    45. Smith HO, Goldberg GL, Carol L, Davidson SA, Tomaino C, Centrilla L, Runowicz CD. Dose escalation combination carboplatin/cyclophosphamide chemotherapy for epithelial ovarian cancer. Eur J Gynaecol Oncol. 1994; 15(6):411-7.
      View in: PubMed
    46. Runowicz CD, Smith HO, Goldberg GL. Multimodality therapy in locally advanced cervical cancer. Curr Opin Obstet Gynecol. 1993 Feb; 5(1):92-8.
      View in: PubMed
    47. Einzig AI, Wiernik PH, Sasloff J, Runowicz CD, Goldberg GL. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol. 1992 Nov; 10(11):1748-53.
      View in: PubMed
    48. O'Hanlan KA, Goldberg GL, Jones JG, Runowicz CD, Ehrlich L, Rodriguez-Rodriguez L. Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature. Gynecol Oncol. 1991 Nov; 43(2):167-72.
      View in: PubMed
    49. O'Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, Rodriguez-Rodriguez L. Virulence of papillary endometrial carcinoma. Gynecol Oncol. 1990 Apr; 37(1):112-9.
      View in: PubMed
    50. Runowicz CD, Wadler S, Rodriguez-Rodriguez L, Litwin P, Shaves M, O'Hanlan KA, Goldberg GL, Tomaino CT, Byrnes R. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol. 1989 Sep; 34(3):395-401.
      View in: PubMed
    Goldberg's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067